Top Biomed Stock Signal: DMAC
Report Date: 06-25-2022
Symbol: DMAC - DiaMedica Therapeutics Inc.
Sector:
Industry:
Top Biomed Stock Signal: DMAC
DiaMedica Therapeutics Inc. (DMAC)
2 Carlson Pkwy N Ste 260
Minneapolis, MINNESOTA 55447
Phone: 17634965454
Website: https://www.diamedica.com
CEO: Mr. Rick Pauls
NASDAQ, Nasdaq Capital Market
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. Its lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which has completed Phase Ib clinical trials for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase II REMEDY trials for the treatment of patients with acute ischemic stroke. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
free trading signals, stock trading signals services, stock trading signals, stock market signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228